Cargando…
The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis
BACKGROUND: By now, the incidence of chronic kidney disease (CKD) is increasing. The development of various CKD is attributed to the continuous aggravation of renal interstitial fibrosis (RIF) in the process of end-stage renal disease (ESRD). Oral treatment of traditional Chinese medicine (TCM) is o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505365/ https://www.ncbi.nlm.nih.gov/pubmed/32957343 http://dx.doi.org/10.1097/MD.0000000000022181 |
_version_ | 1783584795598520320 |
---|---|
author | Yu, Guang Guo, Mao Zou, Junju Zhou, Xiaotao Ma, Yuerong |
author_facet | Yu, Guang Guo, Mao Zou, Junju Zhou, Xiaotao Ma, Yuerong |
author_sort | Yu, Guang |
collection | PubMed |
description | BACKGROUND: By now, the incidence of chronic kidney disease (CKD) is increasing. The development of various CKD is attributed to the continuous aggravation of renal interstitial fibrosis (RIF) in the process of end-stage renal disease (ESRD). Oral treatment of traditional Chinese medicine (TCM) is one of the therapies for RIF. Randomized controlled trials (RCTs) of TCM treatment RIF have been reported, but its effectiveness and safety have yet been systematically investigated. Therefore, through the systematic analysis and meta-analysis, our study will summarize the effectiveness and safety of oral treatment RIF of TCM, in order to provides scientific reference for clinical practice. METHODS: This protocol follows Preferred Reporting Items for Systematic Evaluation and Meta-Analysis. RCTs will be only selected. Such databases as the PubMed, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Excerpt Medical Database (Embase), WanFan Data, Chinese Biomedical Literature Database (CBM), WHO International Clinical Trials Registry Platform will be searched from the inception to June, 2020 to collect the RCTs about taking TCM orally in treating RIF. The literature according to the inclusion and exclusion criteria, data-extracted and the methodological quality evaluated will be performed independently by 2 reviewers. The clinical outcomes including renal function indices (Scr, BUN, 24-hour urinary protein quantity) and Indicators of RIF (TGF-β1, Notch1, Jagged-1). The risk of bias included in the RCTs will be evaluated by the bias risk assessment tool provided in the Cochrane System Evaluation Manual 5.1.0. Review Manager 5.3 provided by the Cochrane collaboration network will be used to process the data. RESULTS AND CONCLUSION: Some more targeted and practical results about the efficacy of taking TCM orally in RIF have been provided by our study. The available evidence suggests that the therapeutic effects of combining TCM with Western medicine therapies is much better for RIF than Western medicine therapies only. |
format | Online Article Text |
id | pubmed-7505365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-75053652020-09-24 The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis Yu, Guang Guo, Mao Zou, Junju Zhou, Xiaotao Ma, Yuerong Medicine (Baltimore) 3800 BACKGROUND: By now, the incidence of chronic kidney disease (CKD) is increasing. The development of various CKD is attributed to the continuous aggravation of renal interstitial fibrosis (RIF) in the process of end-stage renal disease (ESRD). Oral treatment of traditional Chinese medicine (TCM) is one of the therapies for RIF. Randomized controlled trials (RCTs) of TCM treatment RIF have been reported, but its effectiveness and safety have yet been systematically investigated. Therefore, through the systematic analysis and meta-analysis, our study will summarize the effectiveness and safety of oral treatment RIF of TCM, in order to provides scientific reference for clinical practice. METHODS: This protocol follows Preferred Reporting Items for Systematic Evaluation and Meta-Analysis. RCTs will be only selected. Such databases as the PubMed, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Excerpt Medical Database (Embase), WanFan Data, Chinese Biomedical Literature Database (CBM), WHO International Clinical Trials Registry Platform will be searched from the inception to June, 2020 to collect the RCTs about taking TCM orally in treating RIF. The literature according to the inclusion and exclusion criteria, data-extracted and the methodological quality evaluated will be performed independently by 2 reviewers. The clinical outcomes including renal function indices (Scr, BUN, 24-hour urinary protein quantity) and Indicators of RIF (TGF-β1, Notch1, Jagged-1). The risk of bias included in the RCTs will be evaluated by the bias risk assessment tool provided in the Cochrane System Evaluation Manual 5.1.0. Review Manager 5.3 provided by the Cochrane collaboration network will be used to process the data. RESULTS AND CONCLUSION: Some more targeted and practical results about the efficacy of taking TCM orally in RIF have been provided by our study. The available evidence suggests that the therapeutic effects of combining TCM with Western medicine therapies is much better for RIF than Western medicine therapies only. Lippincott Williams & Wilkins 2020-09-18 /pmc/articles/PMC7505365/ /pubmed/32957343 http://dx.doi.org/10.1097/MD.0000000000022181 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 3800 Yu, Guang Guo, Mao Zou, Junju Zhou, Xiaotao Ma, Yuerong The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis |
title | The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis |
title_full | The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis |
title_fullStr | The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis |
title_full_unstemmed | The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis |
title_short | The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis |
title_sort | efficacy of taking traditional chinese medicine orally in renal interstitial fibrosis: a protocol for a systematic review and meta-analysis |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505365/ https://www.ncbi.nlm.nih.gov/pubmed/32957343 http://dx.doi.org/10.1097/MD.0000000000022181 |
work_keys_str_mv | AT yuguang theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT guomao theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT zoujunju theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT zhouxiaotao theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT mayuerong theefficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT yuguang efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT guomao efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT zoujunju efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT zhouxiaotao efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis AT mayuerong efficacyoftakingtraditionalchinesemedicineorallyinrenalinterstitialfibrosisaprotocolforasystematicreviewandmetaanalysis |